RxDoctor Payments Data

Donna Shields, NP

Nurse Practitioner · Quincy, ILNPI 1396718987

Payments from drug & device makers

$4,230in general payments, 2019–2025

Across 187 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$579
  • Takeda Pharmaceuticals U.S.A., Inc.$572
  • Phathom Pharmaceuticals, Inc.$269
  • Gilead$267
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$240
  • plus $624 from 14 others

What the payments were for

  • Food & beverage$4,15598%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,230 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$91,690
Medicare patients
676
Services billed
794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide60$50,968
Omeprazole606$6,541
Dicyclomine Hcl226$5,972
MovantikNaloxegol Oxalate12$4,694
Pantoprazole Sodium374$4,676
Esomeprazole Magnesium19$1,920
Ondansetron Hcl105$1,870
Famotidine272$1,443
Desipramine Hcl22$1,204
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl51$805
Ondansetron OdtOndansetron73$707
Rabeprazole Sodium12$558
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl32$407
LoperamideLoperamide Hcl36$382
Nortriptyline Hcl55$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,678$50,96860 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Quincy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →